Comparison of the performance of two affinity depletion spin filters for quantitative proteomics of CSF: Evaluation of sensitivity and reproducibility of CSF analysis using GeLC-MS/MS and spectral counting

Proteomics - Clinical Applications

Volumn 4, Issue 6-7, 2010, Pages 613-617

  Fratantoni, Silvina A ^a   Piersma, Sander R ^a   Jimenez, Connie R ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cerebrospinal fluid; IgY and MARS based affinity depletion; Reproducibility; Spectral counting; Spin filter

Indexed keywords

ARTICLE; BIOFILTER; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; GEL CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN ISOLATION; PROTEOMICS; QUANTITATIVE STUDY; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SPIN FILTER; TANDEM MASS SPECTROMETRY;

CEREBROSPINAL FLUID PROTEINS; FILTRATION; HUMANS; MASS SPECTROMETRY; PROTEOME; PROTEOMICS;

EID: 77955791992     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900179     Document Type: Article

References (9)

1. Zhang, J., Goodlett, D. R., Montine, T. J., Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases. J. Alzheimers Dis. 2005, 8, 377-386.
2. Westman-Brinkmalm, A., Ruetschi, U., Portelius, E., Andreasson, U. et al., Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases. Front. Biosci. 2009, 14, 1793-1806.
3. Shores, K. S., Knapp, D. R., Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis. J. Proteome Res. 2007, 6, 3739-3751
4. Ogata, Y., Charlesworth, M. C., Muddiman, D. C., Evaluation of protein depletion methods for the analysis of total-, phospho- and glycoproteins in lumbar cerebrospinal fluid. J. Proteome. Res. 2005, 4, 837-845.
5. Ramström, M., Zuberovic, A., Grönwall, C., Hanrieder, J. et al., Development of affinity columns for the removal of high-abundance proteins in cerebrospinal fluid. Biotechnol. Appl. Biochem. 2009, 52, 159-166.
6. Piersma, S. R., Broxterman, H. J., Kapci, M., de Haas, R. R. et al., Proteomics of the TRAP-induced platelet releasate. J. Proteomics. 2009, 72, 91-109.
7. Zougman, A., Pilch, B., Podtelejnikov, A., Kiehntopf, M. et al., Integrated analysis of the cerebrospinal fluid peptidome and proteome. J. Proteome Res. 2008, 7, 386-399.
8. Khwaja, F. W., Reed, M. S., Olson, J. J., Schmotzer, B. J. et al., Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients. J. Proteome. Res. 2007, 6, 559-570.
9. Roy, S., Josephson, S. A., Fridlyand, J., Karch, J. et al., Protein biomarker identification in the CSF of patients with CNS lymphoma. J. Clin. Oncol. 2008, 26, 96-105.